GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G, Luo D, Zhong N, Li D, Zheng J, Liao H, Li Z, Lin X, Chen Q, Zhang C, Lu Y, Chan YT, Ren Q, Wang N, Feng Y.
Chen G, et al. Among authors: ren q.
Front Immunol. 2022 Mar 8;13:857308. doi: 10.3389/fimmu.2022.857308. eCollection 2022.
Front Immunol. 2022.
PMID: 35345673
Free PMC article.